Malabsorption syndrome is a condition that prevents absorption of nutrients such as carbohydrates, fats, proteins, and vitamins through small intestine. It might be caused due to some damage in the small intestine from infection, medication, surgery, or disorders of some sorts.
Report Code : A14378 | Category : Life Sciences
Sjogren’s syndrome is a progressive autoimmune disease, which is caused by chronic inflammation and the lymphocytic infiltration of exocrine glands.
Report Code : A14381 | Category : Life Sciences
Chaple syndrome is also known as DAF or CD55 deficiency, which refers to a genetic disorder that is rare in nature related to the immune system. CHAPLE is ...
Report Code : A14417 | Category : Life Sciences
Aicardi syndrome is a rare genetic disorder, the onset of which begins with involuntary muscle spasm between 4 months to 4 years of age, which, if recurrent, can be fatal at times.
Report Code : A14424 | Category : Life Sciences
Blau syndrome is a monogenic disease that affects skin, eyes, and the joints. A single modification in one gene present in the body’s cell primarily causes this inflammatory disorder where the symptoms start in childhood, usually before the child is 4 years of age.
Report Code : A14425 | Category : Life Sciences
Menkes syndrome is essentially a rare, X-linked genetic disorder of copper metabolism, which is caused by gene mutations of copper transporter ATP7A that disrupts the copper levels in the body and makes it hard for the body to properly distribute the copper throughout the body.
Report Code : A14445 | Category : Life Sciences
Jarcho Levin Syndrome or Spondylocostal Dysostosis is a rare heritable axial skeleton growth disorder and is hence, a condition present by birth. It causes the malformation of vertebral bones, ribs.
Report Code : A14902 | Category : Life Sciences
Duane syndrome, also known as Duane retraction syndrome (DRS), is a non-progressive congenital strabismus caused by faulty development of the 6th cranial nerve.
Report Code : A15371 | Category : Life Sciences
The global cri-du-chat syndrome treatment market was valued at $1.3 million in 2021, and is projected to reach $1.9 million by 2031, growing at a CAGR of 3.7% from 2022 to 2031.
Report Code : A15445 | Pages : 148 | Category : Life Sciences
